Amgen Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
AMGN Nasdaq 2836 www.amgen.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Amgen Inc.

AMGEN ANNOUNCES RETIREMENT OF DAVID M. REESE, EXECUTIVE VICE PRESIDENT AND CHIEF TECHNOLOGY OFFICER - Apr 22nd, 2026 2:00 pm
Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It - Apr 21st, 2026 7:00 am
What to Expect From Amgen's Next Quarterly Earnings Report - Apr 20th, 2026 9:49 am
How to Play J&J Stock Post a Beat-and-Raise Performance in Q1 - Apr 20th, 2026 7:12 am
Zai Lab (ZLAB), Amgen (AMGN) Partner to Evaluate Combination Lung Cancer Therapy - Apr 19th, 2026 9:43 am
Is It Time To Reconsider Amgen (AMGN) After Its Strong Multi Year Share Price Run? - Apr 19th, 2026 3:06 am
2 S&P 500 Stocks Worth Your Attention and 1 We Ignore - Apr 17th, 2026 5:20 pm
Amgen (AMGN) Laps the Stock Market: Here's Why - Apr 17th, 2026 3:50 pm
UBS Sees Continued Upside in Amgen (AMGN), Lifts Target to $400 - Apr 17th, 2026 11:58 am
Evercore ISI Adjusts Viridian Therapeutics, Inc. (VRDN) Outlook in Pre-Earnings Preview - Apr 17th, 2026 7:37 am
Middle East and Africa Biosimilars Market Trends Report 2026-2035, Profiles of AbbVie, Amgen, Biocon, Celltrion, Dr. Reddy's, Pfizer, Roche, Samsung, Sandoz, Teva, Viatris - Apr 17th, 2026 4:17 am
2 Dow Jones Stocks with Exciting Potential and 1 Facing Headwinds - Apr 16th, 2026 1:30 pm
Thyroid Eye Disease Treatment Market Research Report 2026 Featuring Amgen, Viridian, Novartis, Roche, Sanofi, AbbVie, and Teva with Analyst Recommendations and Forecasts to 2031 - Apr 16th, 2026 9:24 am
J&J Targets Double-Digit Growth by 2030 Despite Stelara Drag - Apr 16th, 2026 7:42 am
Greywolf Therapeutics appoints Edwin Moses as Chair - Apr 16th, 2026 12:00 am
2 Reasons to Like AMGN and 1 to Stay Skeptical - Apr 15th, 2026 11:46 am
Amgen And Zai Lab Trial Tests DLL3 Combo As Valuation Looks Undemanding - Apr 14th, 2026 11:03 am
J&J Beats Q1 Earnings & Sales Estimates, Raises 2026 Outlook - Apr 14th, 2026 10:28 am
Morgan Stanley Raises Amgen (AMGN) Target Ahead of Q1, Truist Lifts Outlook on Pipeline Strength - Apr 13th, 2026 2:27 pm
Eosinophilic Esophagitis Market in the US to Grow at 13.2% CAGR During the Forecast Period (2026–2036) Owing to the Emergence of Drug Classes Such as TSLP Inhibitors, Glucocorticoid Receptor Agonists, and Immunomodulators | DelveInsight - Apr 13th, 2026 11:00 am